Geneva, Feb. 13 -- International Clinical Trials Registry received information related to the study (ChiCTR2600118512) titled 'Research on the Mechanism of MECP2 Promoting Diabetic Nephropathy by Targeting the SPI1/NLRP3 Signaling Axis to Inhibit Mitophagy' on Feb. 6.
Study Type: Observational study
Study Design:
Sequential
Primary Sponsor: Zhejiang Provincial People's Hospital
Condition:
Type 2 diabetic nephropathy
Intervention:
DKD group:none
Recruitment Status: Not Recruiting
Phase: N/A
Date of First Enrollment: 2026-03-01
Target Sample Size: DKD group:30;Non-DKD group:30;
Countries of Recruitment:
China
To know more, visit https://www.chictr.org.cn/showproj.html?proj=306834
Disclaimer: Curated by HT Syndication....